T. Rowe Price Investment Management
AGL icon

T. Rowe Price Investment Management’s Agilon Health AGL Stock Holding History

T. Rowe Price Investment Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-382,255
Closed -$120M – 621
2023
Q4 		$120M Sell
382,255
-204,613
-35% -$74.1M 0.08% 248
2023
Q3 		$261M Buy
586,868
+3,153
+0.5% +$1.42M 0.18% 144
2023
Q2 		$253M Buy
583,715
+476,336
+444% +$268M 0.17% 146
2023
Q1 		$63.8M Sell
107,379
-2,068
-2% -$1.16M 0.05% 332
2022
Q4 		$44.2M Buy
109,447
+1,693
+2% +$794K 0.03% 371
2022
Q3 		$63.1M Buy
+107,754
New +$64.5M 0.05% 318

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management's AGL Position: Q1 2024 in Review

T. Rowe Price Investment Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 382,255 shares — an estimated $120M sold.

T. Rowe Price Investment Management first reported a position in AGL in Q3 2022 and held it in 6 quarters. The position peaked at $261M in Q3 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • T. Rowe Price Investment Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 382,255 Agilon Health shares in Q1 2024, an estimated $120M.
  • T. Rowe Price Investment Management first reported a position in Agilon Health in Q3 2022 and held it in 6 quarters.
  • T. Rowe Price Investment Management's Agilon Health position peaked at $261M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2024, filed 15 May 2024.